Axogen, Inc. (NASDAQ:AXGN)

AxoGen, Inc., a regenerative medicine company, provides products and technologies for peripheral nerve reconstruction and regeneration. Its product portfolio comprises Avance Nerve Graft, an allograft nerve for bridging nerve discontinuities; AxoGuard Nerve Connector, a coaptation aid that allows for the close approximation of severed nerves; and AxoGuard Nerve Protector, a surgical implant that protects nerves during the body’s healing process after surgery. The company sells its products in the United States, Canada, Italy, and Switzerland. AxoGen, Inc. is headquartered in Alachua, Florida.

Last updated March 13, 2013


Market Data powered by QuoteMedia. Terms of Use